Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis
解决子宫内膜异位症女性心血管疾病风险加速的机制和干预措施
基本信息
- 批准号:10838754
- 负责人:
- 金额:$ 3.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-15 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAgeAtherosclerosisBeta CellBiomedical ResearchBlood VesselsCardiovascular DiseasesCardiovascular ManifestationCardiovascular systemCause of DeathCellular AssayChronicCoupledCutaneousDiagnosisDiseaseDisease ProgressionEndometriumEndotheliumEstrogensFoundationsGynecologicHealthHealth PersonnelImmuneImpairmentInfertilityInflammationInflammation MediatorsInflammatoryInhibition of NF-KB activationInterleukin-1 betaInterleukin-6InterventionLaboratoriesLaser-Doppler FlowmetryLectinLifeLinkMediatingMicrocirculationMicrodialysisModelingMorbidity - disease rateNF-kappa BNatureNitric OxideNot Hispanic or LatinoOralOutcomeOxidative StressPainPeripheral Blood Mononuclear CellPlacebo ControlPopulationPredispositionPrevalencePrognosisProtocols documentationQualifyingRaceReportingResearchRoleSignal TransductionSiteSymptomsTNF geneTestingTissuesTrainingUterine cavityVascular DiseasesVascular EndotheliumVasodilationWomanWorkblack womenbrachial arterycardiovascular disorder riskcareer developmentchronic pelvic paincomorbiditycytokinedesigndimerdisease diagnosisdisorder riskeffective interventionendometriosisendothelial dysfunctionexperiencehealth care disparityimplicit biasimprovedknock-downmortalityoxidized LDL receptorsoxidized lipidp65parent grantreceptorreproductiveresponsesalicylsalicylic acidsymptomatologysystemic inflammatory response
项目摘要
PROJECT SUMMARY
Despite impacting 1 in 10 women of reproductive age, endometriosis has a delay in diagnosis of 7 years from
the onset of symptoms. In Non-Hispanic Black (NHB) women, despite having a similar prevalence of
endometriosis it is underdiagnosed due to a myriad of factors, including symptomatology-related reporting
biases, healthcare disparities, and implicit biases among both NHB women and healthcare providers. These
factors may contribute to NHB women being half as likely to be diagnosed with endometriosis as compared to
Non-Hispanic White (NHW) women. Importantly, this means that when NHB women do receive an endometriosis
diagnosis, it tends to be later in life resulting in further disease progression and worse prognoses. Given the
increased risk of cardiovascular disease risk in women with endometriosis, the delayed treatment in NHB women
may contribute to the increase in morbidity and mortality from CVD observed in this population. NHB women
have disproportionately higher rates of CVD and overall poorer outcomes compared to their NHW counterparts.
As the parent grant aims to disaggregate the roles of inflammation and oxidative stress contributing to early
manifestations of CVD in women with endometriosis, it is critical to first understand the race-related differences
that underlying these pathophysiological states. Therefore, the proposed studies for this diversity supplement
will systematically interrogate race-related differences in endothelial and microvascular function, providing a
crucial foundation to inform the parent grant and allow us to effectively account for race as a variable in the
overarching study. We will test the hypothesis that impaired endothelial function in healthy non-Hispanic Black
(NHB) women relative to non-Hispanic White (NHW) women is mediated by inflammatory mechanisms. Using a
robust approach to systemically knockdown nuclear factor kappa B cells (NF-κB) in a placebo control design
(oral salsalate), endothelial function will be assessed in the microcirculation (laser Doppler flowmetry coupled
with intradermal microdialysis) and the macrocirculation (brachial artery flow-mediated vasodilation; FMD).
Specific immune cell assays in peripheral blood mononuclear cells (PBMCs) will provide ex vivo evidence to
support of functional vascular studies. This supplement will provide training in biomedical research for a highly
qualified candidate from a diverse background.
项目摘要
尽管影响1/10的育龄妇女,子宫内膜异位症的诊断延迟7年,
症状的出现在非西班牙裔黑人(NHB)妇女中,尽管有类似的患病率,
子宫内膜异位症,它是诊断不足,由于无数的因素,包括子宫内膜异位症相关的报告
偏见,医疗差距,以及NHB妇女和医疗保健提供者之间的隐性偏见。这些
因素可能有助于NHB妇女被诊断为子宫内膜异位症的可能性是一半,
非西班牙裔白色(NHW)女性。重要的是,这意味着当NHB妇女确实接受子宫内膜异位症时,
如果没有诊断,它往往是在以后的生活中,导致进一步的疾病进展和更严重的疾病。鉴于
子宫内膜异位症女性心血管疾病风险增加,NHB女性延迟治疗
可能导致在该人群中观察到的CVD发病率和死亡率增加。NHB女性
心血管疾病的发病率不成比例地更高,与NHW同行相比,总体结果更差。
由于母基金的目的是分解炎症和氧化应激在早期糖尿病中的作用,
子宫内膜异位症女性CVD的表现,首先了解种族相关的差异是至关重要的
这些病理生理状态的基础。因此,为这种多样性补充拟议的研究
将系统地询问内皮和微血管功能中与种族相关的差异,
至关重要的基础,以告知家长补助金,使我们能够有效地考虑种族作为一个变量,
总体研究。我们将检验健康的非西班牙裔黑人中内皮功能受损的假设,
(NHB)与非西班牙裔白色(NHW)女性相比,使用
安慰剂对照设计中系统性敲低核因子κ B细胞(NF-κB)的稳健方法
(oral双水杨酸酯),将在微循环中评估内皮功能(激光多普勒血流仪耦合
皮内微透析)和大循环(肱动脉血流介导的血管舒张; FMD)。
外周血单个核细胞(PBMC)中的特异性免疫细胞测定将提供离体证据,
支持功能性血管研究。这一补充将提供生物医学研究的培训,
来自不同背景的合格候选人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lacy M. ALEXANDER其他文献
Lacy M. ALEXANDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lacy M. ALEXANDER', 18)}}的其他基金
Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis
解决子宫内膜异位症女性心血管疾病风险加速的机制和干预措施
- 批准号:
10340678 - 财政年份:2022
- 资助金额:
$ 3.72万 - 项目类别:
Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis
解决子宫内膜异位症女性心血管疾病风险加速的机制和干预措施
- 批准号:
10631533 - 财政年份:2022
- 资助金额:
$ 3.72万 - 项目类别:
Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis
解决子宫内膜异位症女性心血管疾病风险加速的机制和干预措施
- 批准号:
10749132 - 财政年份:2022
- 资助金额:
$ 3.72万 - 项目类别:
Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis
解决子宫内膜异位症女性心血管疾病风险加速的机制和干预措施
- 批准号:
10545738 - 财政年份:2022
- 资助金额:
$ 3.72万 - 项目类别:
Essential Hypertension and Human Skin Blood Flow
原发性高血压与人体皮肤血流量
- 批准号:
7894731 - 财政年份:2009
- 资助金额:
$ 3.72万 - 项目类别:
Essential Hypertension and Human Skin Blood Flow
原发性高血压与人体皮肤血流量
- 批准号:
7505362 - 财政年份:2009
- 资助金额:
$ 3.72万 - 项目类别:
Essential Hypertension and Human Skin Blood Flow
原发性高血压与人体皮肤血流量
- 批准号:
8403964 - 财政年份:2009
- 资助金额:
$ 3.72万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 3.72万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 3.72万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 3.72万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 3.72万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 3.72万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 3.72万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 3.72万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 3.72万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 3.72万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 3.72万 - 项目类别:
Research Grant